Nail Society of India Recommendations for Treatment of Onychomycosis in Special Population Groups.

IF 1.9 Q3 DERMATOLOGY Indian Dermatology Online Journal Pub Date : 2024-02-28 eCollection Date: 2024-03-01 DOI:10.4103/idoj.idoj_578_23
Khushbu Mahajan, Chander Grover, Vineet Relhan, Sushil Tahiliani, Archana Singal, Manjunath M Shenoy, Deepak Jakhar, Shikha Bansal
{"title":"Nail Society of India Recommendations for Treatment of Onychomycosis in Special Population Groups.","authors":"Khushbu Mahajan, Chander Grover, Vineet Relhan, Sushil Tahiliani, Archana Singal, Manjunath M Shenoy, Deepak Jakhar, Shikha Bansal","doi":"10.4103/idoj.idoj_578_23","DOIUrl":null,"url":null,"abstract":"<p><p>Onychomycosis (OM) is a difficult-to-treat condition, especially considering the limited armamentarium of antifungal drugs, need for prolonged treatment, and poor compliance. This problem is further confounded while treating OM in special populations such as children, elderly, immunosuppressed patients, pregnant or lactating women, and patients with chronic liver or kidney disease. In the absence of standardized treatment guidelines, the antifungal therapy is either withheld or compromised, as it is largely governed by personal preferences or based on anecdotal reports. Hence, an expert group of the Nail Society of India worked towards drafting guidelines based on established literature and inputs from experts, with practical recommendations for the treatment of onychomycosis in special population groups. An extensive analysis of available English language literature on onychomycosis in special populations, published during a 10-year period (2014-2023 until date) was done. The available studies and reports were evaluated, cross-references read, and evidence compiled, graded, and discussed by the expert group to derive consensus recommendations for practice. The evidence and recommendations based on it are presented in a narrative format to guide treatment choices when dealing with population groups with special considerations.</p>","PeriodicalId":13335,"journal":{"name":"Indian Dermatology Online Journal","volume":"15 2","pages":"196-204"},"PeriodicalIF":1.9000,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10969234/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Dermatology Online Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/idoj.idoj_578_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Onychomycosis (OM) is a difficult-to-treat condition, especially considering the limited armamentarium of antifungal drugs, need for prolonged treatment, and poor compliance. This problem is further confounded while treating OM in special populations such as children, elderly, immunosuppressed patients, pregnant or lactating women, and patients with chronic liver or kidney disease. In the absence of standardized treatment guidelines, the antifungal therapy is either withheld or compromised, as it is largely governed by personal preferences or based on anecdotal reports. Hence, an expert group of the Nail Society of India worked towards drafting guidelines based on established literature and inputs from experts, with practical recommendations for the treatment of onychomycosis in special population groups. An extensive analysis of available English language literature on onychomycosis in special populations, published during a 10-year period (2014-2023 until date) was done. The available studies and reports were evaluated, cross-references read, and evidence compiled, graded, and discussed by the expert group to derive consensus recommendations for practice. The evidence and recommendations based on it are presented in a narrative format to guide treatment choices when dealing with population groups with special considerations.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
印度美甲协会关于特殊人群甲癣治疗的建议。
甲癣(OM)是一种难以治疗的疾病,尤其是考虑到抗真菌药物种类有限、需要长期治疗以及依从性差等因素。在治疗儿童、老年人、免疫抑制患者、孕妇或哺乳期妇女、慢性肝病或肾病患者等特殊人群的真菌病时,这一问题更加复杂。在缺乏标准化治疗指南的情况下,抗真菌治疗要么被搁置,要么大打折扣,因为这在很大程度上取决于个人喜好或基于传闻。因此,印度美甲协会的一个专家小组根据已有文献和专家意见,努力起草指南,为特殊人群的甲癣治疗提供实用建议。专家组对 10 年内(2014-2023 年至今)发表的有关特殊人群甲癣的现有英文文献进行了广泛分析。专家组对现有的研究和报告进行了评估,阅读了交叉参考文献,并对证据进行了汇编、分级和讨论,从而得出了一致的实践建议。证据和基于证据的建议以叙述的形式呈现,以便在处理有特殊考虑的人群时为治疗选择提供指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.00
自引率
11.80%
发文量
201
审稿时长
49 weeks
期刊最新文献
Bicalutamide in Dermatology: A Narrative Review. Clinicopathological Profile of Pyoderma Gangrenosum: A 10-Year Retrospective Study from a Tertiary Care Center in South India. Novel Inflammatory Markers Associated With Cutaneous Leukocytoclastic Vasculitis Etiology. Pediatric Basidiobolomycosis: An Uncommon and Misdiagnosed Entity. Premature Graying of Hair: A Comprehensive Review and Recent Insights.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1